Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases-Reference-Cited by-同舟云学术

Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases

Published:2011-04-14 Issue:4 Volume:7 Page:e1002020
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Wilen Craig B.,Wang Jianbin,Tilton John C.,Miller Jeffrey C.,Kim Kenneth A.,Rebar Edward J.,Sherrill-Mix Scott A.,Patro Sean C.,Secreto Anthony J.,Jordan Andrea P. O.,Lee Gary,Kahn Joshua,Aye Pyone P.,Bunnell Bruce A.,Lackner Andrew A.,Hoxie James A.,Danet-Desnoyers Gwenn A.,Bushman Frederic D.,Riley James L.,Gregory Philip D.,June Carl H.,Holmes Michael C.,Doms Robert W.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference62 articles.

1. Entry inhibitors in the treatment of HIV-1 infection.;JC Tilton;Antiviral Res,2010

2. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.;R Liu;Cell,1996

3. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.;M Samson;Nature,1996

4. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.;M Dean;Science,1996

5. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.;Y Huang;Nat Med,1996

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently;Clinical and Experimental Medicine;2023-07-27

2. Precise excision of HTLV-1 provirus with a designer-recombinase;Molecular Therapy;2023-07

3. HIV cure strategies: which ones are appropriate for Africa?;Cellular and Molecular Life Sciences;2022-07-06

4. Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections;Biomedicine & Pharmacotherapy;2022-04

5. CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice;Molecular Therapy - Methods & Clinical Development;2022-03